Skip to main content
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
vincenzo.tombolini@uniroma1.it
Vincenzo Tombolini
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE RADIOLOGICHE, ONCOLOGICHE E ANATOMO-PATOLOGICHE
E-mail:
vincenzo.tombolini@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Publications
Title
Published on
Year
Diffusion-weighted magnetic resonance imaging in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
2017
Pulsed-dose rate brachytherapy for the treatment of endometrial cancer
ONCOLOGY
2017
Critical decision-making in radiotherapy for early stage breast cancer in a neo-adjuvant treatment era
EXPERT REVIEW OF ANTICANCER THERAPY
2017
Definitive intensity-modulated radiation therapy in elderly patients with locally advanced oropharyngeal cancer
IN VIVO
2017
Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer
BMC CANCER
2017
Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT: a case report
MEDICINE
2017
The addition of target therapy to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a review
CHEMOTHERAPY
2017
Radiation therapy and serum salivary amylase in head and neck cancer
ONCOTARGET
2017
Follow-up program in head and neck cancer
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2017
Head and neck diffuse large B cell lymphomas (HN-DLBCL) in human immunodeficiency virus (HIV) positive patients: long-term results in the highly active antiretroviral therapy (HAART) era
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
2017
Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy. results from a monoinstitutional cohort analysis of long-term survivors
HEMATOLOGICAL ONCOLOGY
2017
Multimodality treatment of stage II thymic tumours
JOURNAL OF THORACIC DISEASE
2017
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells
JOURNAL OF HEMATOLOGY & ONCOLOGY
2017
Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: an evidence-based approach on what women should know
CANCER TREATMENT REVIEWS
2017
Excess of weight: is it a modifiable predictive and prognostic factor in locally advanced rectal cancer?
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
2017
Relation between hypofractionated radiotherapy, toxicity and outcome in early breast cancer
THE BREAST JOURNAL
2017
Defective DNA repair mechanisms in prostate cancer: impact of olaparib
DRUG DESIGN, DEVELOPMENT AND THERAPY
2017
Anorectal function and quality of life after chemoradiotherapy in patients with canal carcinoma
CANCER BREAKING NEWS
2017
Management of salivary gland malignant tumor: the Policlinico Umberto I, "Sapienza" University of Rome Head and Neck Unit clinical recommendations
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2017
Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer
ONCOTARGET
2017
« first
< previous
1
2
3
4
5
6
7
8
9
10
11
next >
last »
ERC
LS4_12
LS7_1
LS7_6
KET
Life-science technologies & biotechnologies
Interessi di ricerca
Keywords
Adult cancer
aggressive cancer
Medical Oncology
BASI BIOLOGICHE DEL CANCRO
3d conformal radiotherapy
imrt-sib
IMRT
cancer biology
conformal radiotherapy and stereotactic body radiotherapy
Progetti di Ricerca
Induction chemotherapy in patients with anal canal cancer: a pilot study
Hypofractionated radiotherapy plus cetuximab for head and neck carcinoma in elderly patients: a pilot study.
TARGETING HIGHLY AGGRESSIVE RADIATION RESISTANT CANCERS: MULTIDISCIPLINARY INVESTIGATION OF THE MOLECULAR BASIS OF THE SYNERGY BETWEEN LOW RADIATION THERAPY DOSES AND INNOVATIVE MICROTUBULE TARGETING RADIOSENSITIZER AGENTS.
microRNA PROFILING OF CANCER STEM CELLS FROM PATIENTS WITH ANAL and RECTAL CANCER: IDENTIFYING PREDICTIVE BIOMARKERS OF RADIATION RESPONSE
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma